miR-92b regulates glioma cells proliferation, migration, invasion, and apoptosis via PTEN/Akt signaling pathway

[1]  Guixiu Shi,et al.  MicroRNA-20b promotes cell growth of breast cancer cells partly via targeting phosphatase and tensin homologue (PTEN) , 2014, Cell & Bioscience.

[2]  Qiang Liu,et al.  MiR-136 modulates glioma cell sensitivity to temozolomide by targeting astrocyte elevated gene-1 , 2014, Diagnostic Pathology.

[3]  Y. Zhang,et al.  MicroRNA-492 expression promotes the progression of hepatic cancer by targeting PTEN , 2014, Cancer Cell International.

[4]  Ping Yang,et al.  miR-19a acts as an oncogenic microRNA and is up-regulated in bladder cancer , 2014, Journal of Experimental & Clinical Cancer Research.

[5]  M. Wolter,et al.  MicroRNA-mediated down-regulation of NKG2D ligands contributes to glioma immune escape , 2014, Oncotarget.

[6]  Yi Sun,et al.  MicroRNA-222 promotes the proliferation and migration of cervical cancer cells. , 2014, Clinical and investigative medicine. Medecine clinique et experimentale.

[7]  Julia B. Cordero,et al.  MicroRNA-135b Promotes Cancer Progression by Acting as a Downstream Effector of Oncogenic Pathways in Colon Cancer , 2014, Cancer cell.

[8]  Lei Shen,et al.  RETRACTED ARTICLE: MicroRNA-128 promotes proliferation in osteosarcoma cells by downregulating PTEN , 2014, Tumor Biology.

[9]  Cao Yang,et al.  miR-17 inhibitor suppressed osteosarcoma tumor growth and metastasis via increasing PTEN expression. , 2014, Biochemical and biophysical research communications.

[10]  Feng Li,et al.  [miR-221 mediates epithelial-mesenchymal transition-related gene expressions via regulation of PTEN/Akt signaling in drug-resistant glioma cells]. , 2014, Nan fang yi ke da xue xue bao = Journal of Southern Medical University.

[11]  Jin-Ching Lee,et al.  The antiproliferative effect of C2-ceramide on lung cancer cells through apoptosis by inhibiting Akt and NFκB , 2014, Cancer Cell International.

[12]  B. Casini,et al.  Early-onset colorectal cancer patients without family history are “at very low risk” for lynch syndrome , 2014, Journal of experimental & clinical cancer research : CR.

[13]  Jianwen Liu,et al.  MiR-92b inhibitor promoted glioma cell apoptosis via targeting DKK3 and blocking the Wnt/beta-catenin signaling pathway , 2013, Journal of Translational Medicine.

[14]  Li Li,et al.  MiR-92b regulates the cell growth, cisplatin chemosensitivity of A549 non small cell lung cancer cell line and target PTEN. , 2013, Biochemical and biophysical research communications.

[15]  D. Cui,et al.  MicroRNA-218 inhibits glioma invasion, migration, proliferation, and cancer stem-like cell self-renewal by targeting the polycomb group gene Bmi1. , 2013, Cancer research.

[16]  Yu Yao,et al.  The miR-92b functions as a potential oncogene by targeting on Smad3 in glioblastomas , 2013, Brain Research.

[17]  Stephen T. C. Wong,et al.  The miR-223/Nuclear Factor I-A Axis Regulates Glial Precursor Proliferation and Tumorigenesis in the CNS , 2013, The Journal of Neuroscience.

[18]  P. Pu,et al.  miR-92b controls glioma proliferation and invasion through regulating Wnt/beta-catenin signaling via Nemo-like kinase. , 2013, Neuro-oncology.

[19]  A. Pandurangan,et al.  Potential targets for prevention of colorectal cancer: a focus on PI3K/Akt/mTOR and Wnt pathways. , 2013, Asian Pacific journal of cancer prevention : APJCP.

[20]  Thomas Tuschl,et al.  miRNAs in human cancer , 2011, The Journal of pathology.

[21]  Susan M. Chang,et al.  Recent advances in therapy for glioblastoma. , 2010, Archives of neurology.

[22]  Erwin G. Van Meir,et al.  Tumor initiating cells in malignant gliomas: biology and implications for therapy , 2009, Journal of Molecular Medicine.

[23]  D. Bartel.  MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.

[24]  S. Baker,et al.  PTEN signaling in brain: neuropathology and tumorigenesis , 2008, Oncogene.

[25]  Iris Barshack,et al.  MiR‐92b and miR‐9/9* Are Specifically Expressed in Brain Primary Tumors and Can Be Used to Differentiate Primary from Metastatic Brain Tumors , 2008, Brain pathology.

[26]  Sarka Pospisilova,et al.  MicroRNA biogenesis, functionality and cancer relevance. , 2006, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia.

[27]  R. Campbell,et al.  The Protein Kinase Cβ–Selective Inhibitor, Enzastaurin (LY317615.HCl), Suppresses Signaling through the AKT Pathway, Induces Apoptosis, and Suppresses Growth of Human Colon Cancer and Glioblastoma Xenografts , 2005 .

[28]  R. Shiekhattar,et al.  MicroRNA biogenesis and cancer. , 2005, Cancer research.

[29]  V. Ambros.  The functions of animal microRNAs , 2004, Nature.

[30]  H. Grossman,et al.  In vivo gene therapy of human bladder cancer with PTEN suppresses tumor growth, downregulates phosphorylated Akt, and increases sensitivity to doxorubicin , 2003, Gene Therapy.

[31]  F. Davis,et al.  Current epidemiological trends and surveillance issues in brain tumors , 2001, Expert review of anticancer therapy.

[32]  S. Cannistra,et al.  Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas. , 2001, The American journal of pathology.

[33]  L. Cantley,et al.  New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Tomohiko Maehama,et al.  The Tumor Suppressor, PTEN/MMAC1, Dephosphorylates the Lipid Second Messenger, Phosphatidylinositol 3,4,5-Trisphosphate* , 1998, The Journal of Biological Chemistry.

[35]  W. K. Alfred Yung,et al.  Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers , 1997, Nature Genetics.

[36]  Zhu Jianwei,et al.  MicroRNA 181a improves proliferation and invasion, suppresses apoptosis of osteosarcoma cell , 2013, Tumor Biology.

[37]  G. Alexiou,et al.  The role of the PTEN gene in malignant gliomas. , 2010, Neurologia i neurochirurgia polska.